CorDx Inc.  

9540 Waples St.
Suite C
San Diego,  CA  92121

United States
https://www.CorDx.com

• Booth: 849

CorDx, A CorDx Union company , a transforming the global diagnostics industry with innovative R&D solutions, a vertically integrated supply chain, and manufacturing footprints in the United States and around the world. Our proprietary line of rapid diagnostic products is recognized by families and medical professionals for reliability, affordability, and rapid results.

 Press Releases

• CorDx Receives Emergency Use Authorization for 10-Min Multiplex Flu A/B & C (May 13, 2024)

  CorDx, a global leader in the development, manufacturing, and distribution of diagnostics and other medical devices, recently received Emergency Use Authorization (EUA) for its CorDx Tyfast Flu A/B & COVID-19 Multiplex Rapid Test.  

   

  
   

• Aiiso Yufeng Li Family Gifts $2.1 Million to Bolster NanoEngineering Dept. (May 13, 2024)
  Through CorDx, founder and Chief Strategy Officer (CSO) Aiiso Yufeng “Jeff” Li alongside the Li family, has pledged $2.1 million to the University of California San Diego Jacobs School of Engineering. The gift will bolster research programs, educational foundations and student development in the Department of NanoEngineering at the Jacobs School of Engineering.   

• CorDx Pledges $3 Million Gift to Boost Sustainable Energy Innovation at UC (May 13, 2024)
  Through CorDx, founder and Chief Strategy Officer (CSO) Aiiso Yufeng “Jeff” Li and Dongdong “Doreen” Guo have pledged $3 million to the University of California San Diego Jacobs School of Engineering. The gift will support cutting-edge research, education, and collaborations at the Sustainable Power and Energy Center (SPEC). 

• CorDx to Launch 10-Minute Solution for Distinguishing Flu A/B, COVID-19 As (May 13, 2024)
  Against the backdrop of a concerning surge in respiratory diseases leading to widespread alarm across the United States, CorDx has submitted its application for its ⁠CorDx TyFast Flu A/B & COVID-19 Multiplex Rapid Test for FDA’s review. This cutting-edge multiplex test aims to deliver results in just 10 minutes and establishes a new benchmark for detecting and distinguishing the nucleocapsid protein antigens of COVID-19, influenza A, and influenza B.

• CorDx to Launch New Global Brand, CuPet, in Singapore (May 13, 2024)
  CorDx will take a revolutionary step in animal healthcare with the official global launch of CuPet at the 2023 Singapore Vet Show. CuPet aims to be customers' first choice in animal health, offering a one-stop solution for all diagnostic needs.